Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diopathic Pulmonary Fibrosis”

601 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 601 results

Not applicableStudy completedNCT03326089
What this trial is testing

Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Corfu General Hospital 20
Early research (Phase 1)Study completedNCT04069143
What this trial is testing

Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

Who this might be right for
Healthy ParticipantsIdiopathic Pulmonary Fibrosis (IPF)
Bristol-Myers Squibb 14
Testing effectiveness (Phase 2)Study completedNCT06331624
What this trial is testing

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisIPF
GRI Bio Operations, Inc. 35
Not applicableStudy completedNCT04864990
What this trial is testing

Dyspnea and Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University Hospital, Lille 51
Not applicableNo Longer AvailableNCT02230982
What this trial is testing

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim
Very early researchLooking for participantsNCT06853145
What this trial is testing

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Virginia 6
Not applicableStudy completedNCT04177251
What this trial is testing

Cardiovascular Fibrosis in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisCardiac FibrosisArterial Fibrosis
San Gerardo Hospital 100
Not applicableStudy completedNCT05113654
What this trial is testing

Sleep Disorders in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Wissenschaftliches Institut Bethanien e.V 78
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Early research (Phase 1)Looking for participantsNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Not applicableStudy completedNCT05784207
What this trial is testing

An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseRadiomics
Maastricht University 145
Testing effectiveness (Phase 2)Study completedNCT05722964
What this trial is testing

Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT02477709
What this trial is testing

Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 6
Testing effectiveness (Phase 2)Study completedNCT05483907
What this trial is testing

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bridge Biotherapeutics, Inc. 129
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583589
What this trial is testing

Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
First Affiliated Hospital of Wenzhou Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Testing effectiveness (Phase 2)Study completedNCT05185089
What this trial is testing

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
CoughIdiopathic Pulmonary Fibrosis
Nerre Therapeutics Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT02412020
What this trial is testing

Treatment of Refractory Chronic Cough With PA101

Who this might be right for
Refractory Chronic Cough
Patara Pharma 52
Early research (Phase 1)Study completedNCT05657184
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001

Who this might be right for
Idiopathic Pulmonary Fibrosis
Regend Therapeutics 12
Testing effectiveness (Phase 2)UnknownNCT05373914
What this trial is testing

RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Blade Therapeutics 200
Load More Results